tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS

Xeris Pharmaceuticals (XERS) Revenue

Compare
1,083 Followers

Xeris Pharmaceuticals Revenue

Xeris Pharmaceuticals had a revenue of 74.38M in the quarter ending Sep 30, 2025, with 3.97%. This bring the company's revenue in the last twelve months to 266.14M, Decreased 8.17%. In the fiscal year ending Dec 31, 2024, Xeris Pharmaceuticals had annual revenue of 203.07M with 23.89% growth.
Revenue (ttm)
266.14M
Revenue Growth
42.05%
P/S Ratio
5.78
Revenue/Employee
$515,406
Employees
394
Market Cap
$1.17B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
203.07M39.16M+123.89%
Dec 31, 2023
163.91M0.00+100.00%
Dec 31, 2023
163.91M0.00+100.00%
Dec 31, 2023
163.91M0.00+100.00%
Dec 31, 2023
163.91M53.67M+148.68%
Dec 31, 2022
110.25M60.66M+222.32%
Dec 31, 2021
49.59M29.16M+242.67%
Dec 31, 2020
20.43M17.71M+750.74%
Dec 31, 2019
2.72M257.00K+110.43%
Dec 31, 2018
2.46M909.00K+158.42%